- NETSPOT GALLIUM 68 DOTATATE GENERATOR
- NETSPOT GALLIUM 68 DOTATATE REGISTRATION
- NETSPOT GALLIUM 68 DOTATATE LICENSE
Verify the injected radioactivity by measuring the radioactivity of the vial containing the Ga 68ĭotatate injection with a dose calibrator before administration to the patient.
NETSPOT GALLIUM 68 DOTATATE GENERATOR
Imaging is 2 MBq/kg of body weight (0.054 mCi/kg) up to 200 MBq (5.4 mCi).Īfter reconstitution with Ga 68 chloride eluate from an Eckert & Ziegler GalliaPharm GermaniumĦ8/Gallium 68 (Ge 68/Ga 68) generator and buffer, administer Ga 68ĭotatate by intravenous injection (bolus). In adults and pediatric patients, the recommended amount of radioactivity to be administered for PET Drink and void frequently during the first hours followingĪdministration to reduce radiation exposure.ģ.2 Recommended Dosage and Administration Instructions Instruct patients to drink a sufficient amount of water to ensure adequate hydration prior toĪdministration of Ga 68 dotatate.
NETSPOT GALLIUM 68 DOTATATE LICENSE
Specific training and experience in the safe use and handling of radionuclides, and whose experienceĪnd training have been approved by the appropriate governmental agency authorized to license the use Radiopharmaceuticals should be used by or under the control of physicians who are qualified by
Gloves, effective radiation shielding and appropriate safety measures when preparing and handling DOSAGE AND ADMINISTRATIONĪfter reconstitution and radiolabeling, handle the Ga 68 dotatate injection with appropriate safety (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and Ga 68 dotatate, after radiolabeling with Ga 68, is indicated for use with positron emission tomography Table 3: Physical Decay Chart for Gallium Ga 68 Table 2: Radiation Attenuation of 511 keV Photons by Lead (Pb) Shielding Table 1: Principal Radiation Emission Data (>1%) Radiation attenuation by lead shielding, and physical decay of Ga 68. Table 1, Table 2, and Table 3 display the principle radiation emission data, The prepared Ga 68ĭotatate injection for intravenous use, is a sterile, pyrogen free, clear, colorless, buffered solution, withĪ pH -between 3.2 - 3.8. Accessory cartridge contains: 660 mg porous silica.Īfter reconstitution and radiolabeling,, Ga 68 dotatate injectionĪlso contains hydrochloric acid as an excipient derived from the generator eluate.Vial 2 (buffer vial) contains: 60 mg formic acid 56.5 mg sodium hydroxide and water for.Vial 1 (reaction vial with lyophilized powder) contains: 40 mcg dotatate, 5 mcg 1,10-phenanthroline.Ga 68 dotatate is a Kit with the following components: Ga 68 dotatate is supplied as a sterile, single-dose kit for preparation of Ga 68 dotatate injection for L)-Tyrosyl-(D)-Tryptophanyl-(L)-Lysyl-(L)-Threoninyl-(L)-Cysteinyl-(L)-Threonine-cyclic(27) The peptide has the amino acid sequence: H-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys.
NETSPOT GALLIUM 68 DOTATATE REGISTRATION
If you opt-out your email will still be collected for registration purposes.Dotatate, also known as DOTA-0-Tyr3-Octreotate, is a cyclic 8 amino acid peptide with a covalentlyīound chelator (dota). You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address.
How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. By accessing or using the AdisInsight platform you agree to the terms of use.
0 kommentar(er)
